Retinal and Peripheral Nerve Toxicity Induced by the Administration of a Pan-Cyclin Dependent Kinase (cdk) Inhibitor in Mice:

作者: Oscar Illanes , Scott Anderson , Michael Niesman , Laura Zwick , Bart A. Jessen

DOI: 10.1080/01926230600713186

关键词:

摘要: Cyclin-dependent kinases (cdks) play a crucial role in cell cycle regulation and are considered promising targets for cancer therapy. Intravenous administration of AG-012986, pan-cyclin-dependent kinase inhibitor (cdki), resulted unexpected retinal peripheral nerve toxicity mice. AG-012986 was administered daily to CD-1 or B6C3F1 mice 5 consecutive days. Mice were euthanized 24 h after the last dose (study day 6) 21-day post-dose period 26). Compound related microscopic findings seen sciatic nerves (axonal degeneration) both strains retina (retinal degeneration/atrophy) only period. Although degeneration/atrophy not detected by routine histology on 6, apoptotic cells evident at this time using TUNEL assay. To our knowledge secondary cdkis has been previously reported. pathogenesis these lesions is unclear, toxicities may reflect unique profile cdk inhibition, off-target inhibition receptor binding, metabolism/distribution properties AG-012986. Multi-targeted-inhibitors interfere with cdks other involved wide range functions than regulation, which could result that hinder their clinical applications.

参考文章(13)
Akio Yamazaki, Oleg Moskvin, Russell K. Yamazaki, Phosphorylation by Cyclin-Dependent Protein Kinase 5 Of The Regulatory Subunit (Pγ) Of Retinal cGMP Phosphodiesterase (PDE6): Its Implications In Phototransduction Advances in Experimental Medicine and Biology. ,vol. 514, pp. 131- 153 ,(2002) , 10.1007/978-1-4615-0121-3_9
Gerin G, Durand-Cavagna G, Hubert Mf, Spontaneous ophthalmic lesions in young Swiss mice. Laboratory Animal Science. ,vol. 49, pp. 232- 240 ,(1999)
Hidetoshi Ino, Toshiharu Ishizuka, Tanemichi Chiba, Masamiti Tatibana, Expression of CDK5 (PSSALRE kinase), a neural cdc2-related protein kinase, in the mature and developing mouse central and peripheral nervous systems. Brain Research. ,vol. 661, pp. 196- 206 ,(1994) , 10.1016/0006-8993(94)91197-5
Fumio Hayashi, Isao Matsuura, Shu Kachi, Tomoko Maeda, Maki Yamamoto, Yuka Fujii, Han Liu, Matsuyo Yamazaki, Jiro Usukura, Akio Yamazaki, Phosphorylation by cyclin-dependent protein kinase 5 of the regulatory subunit of retinal cGMP phosphodiesterase. II. Its role in the turnoff of phosphodiesterase in vivo. Journal of Biological Chemistry. ,vol. 275, pp. 32958- 32965 ,(2000) , 10.1074/JBC.M000703200
C. Masson, Ph. Boulu, D. Hénin, Les neuropathies iatrogènes Revue de Médecine Interne. ,vol. 13, pp. 225- 232 ,(1992) , 10.1016/S0248-8663(05)81333-5
Michelle D Garrett, Ali Fattaey, CDK inhibition and cancer therapy. Current Opinion in Genetics & Development. ,vol. 9, pp. 104- 111 ,(1999) , 10.1016/S0959-437X(99)80015-X
Isao Matsuura, Vladimir A. Bondarenko, Tomoko Maeda, Shu Kachi, Matsuyo Yamazaki, Jiro Usukura, Fumio Hayashi, Akio Yamazaki, Phosphorylation by Cyclin-dependent Protein Kinase 5 of the Regulatory Subunit of Retinal cGMP Phosphodiesterase: I. IDENTIFICATION OF THE KINASE AND ITS ROLE IN THE TURNOFF OF PHOSPHODIESTERASE IN VITRO Journal of Biological Chemistry. ,vol. 275, pp. 32950- 32957 ,(2000) , 10.1074/JBC.M000702200
Constance Visovsky, Chemotherapy-induced peripheral neuropathy. Cancer Investigation. ,vol. 21, pp. 439- 451 ,(2003) , 10.1081/CNV-120018236
Glenn Liu, David R. Gandara, Primo N. Lara, Derek Raghavan, James H. Doroshow, Przemyslaw Twardowski, Philip Kantoff, William Oh, KyungMann Kim, George Wilding, A Phase II Trial of Flavopiridol (NSC #649890) in Patients with Previously Untreated Metastatic Androgen-Independent Prostate Cancer Clinical Cancer Research. ,vol. 10, pp. 924- 928 ,(2004) , 10.1158/1078-0432.CCR-03-0050